Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 1,073.95
-1.75 (-0.16%)
Nov 12, 2026, 3:29 PM IST
Sakar Healthcare Market Cap
Sakar Healthcare has a market cap or net worth of 23.9 billion as of November 12, 2026. It is the 19,041st most valuable company in the world and the 1,173rd biggest in India. Its market cap has increased by 165.37% in one year.
Market Cap
23.90B
Enterprise Value
24.51B
Revenue
3.03B
Global Rank
Country Rank
#1,173 India
PE Ratio
55.57
ChartMarket Cap Chart
Since October 11, 2017, Sakar Healthcare's market cap has increased from 560.11M to 23.90B, an increase of 4,166.20%. That is a compound annual growth rate of 51.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 23.86B | 162.05% |
| Dec 31, 2025 | 9.10B | 41.21% |
| Dec 31, 2024 | 6.45B | -15.35% |
| Dec 29, 2023 | 7.62B | 82.44% |
| Dec 30, 2022 | 4.18B | 49.95% |
| Dec 31, 2021 | 2.78B | 89.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 52.94B |
| RPG Life Sciences | 42.94B |
| Solara Active Pharma Sciences | 31.27B |
| Ind-Swift Laboratories | 30.35B |
| Indoco Remedies | 20.25B |
| Windlas Biotech | 20.10B |
| Beta Drugs | 19.07B |
| Jagsonpal Pharmaceuticals | 14.36B |